Position in FENC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$285,562
+$218,546 QoQ
Shares Held
26,564
+143.8% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 104 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FENC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. FENC ranks #223 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in FENC
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $285,562 | 26,564 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $67,016 | 10,897 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $201,424 | 26,159 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $159,260 | 17,015 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $118,349 | 14,259 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $83,195 | 13,661 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $83,120 | 13,152 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $49,985 | 9,997 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $59,236 | 9,695 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $66,931 | 6,019 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $58,613 | 5,224 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $31,061 | 4,136 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $61,368 | 6,950 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $2,545 | 306 | Shares | Defined | 2023-05-12 | |
| 2021-09-30 | $13,188 | 1,400 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,206 | 1,400 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,154,494 | 185,909 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $409,511 | 54,968 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $308,126 | 50,846 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $106,454 | 12,749 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $10,692 | 1,800 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||